New York (December 24th, 2012) - Ameristar Casinos Inc. (NASDAQ: ASCA), a developer, owner and operator of casino entertainment facilities, is marginally lower in mid-day trading today. At last check, ASCA was trading 0.11% higher at $26.53 on volume of 448,335, which is below the daily average of 644,004.

ASCA had rallied on Friday, finishing more than 20% higher after the company agreed to be acquired by Pinnacle Entertainment Inc. (NYSE: PNK) for approximately $900 million. PNK offered to acquire ASCE for $26.50 per share, which represents a 20% premium over ASCA's closing price last Thursday. The transaction has already been approved by the Board of Directors of both companies.

Find out if ASCA could pick up more steam in the upcoming trading sessions by getting the free full report here: http://www.wallstreetreport.net/market-scan/?symbol=ASCA

Cellceutix Corp. (OTCQB: CTIX), a development stage biopharmaceutical company engaged in the discovery and development of small molecule drugs, is soaring in mid-day trading today, extending its gains from last week. CTIX has finished higher in each of the previous six trading sessions.

The stock is soaring today after the company commented on the New York Times article heralding p53 drugs as the new age in cancer research. The article, Genetic Gamble, New Approaches to Fighting Cancer, was published in the New York Times on December 23, 2012.

CTIX is currently trading 13.83% higher at $2.14 on volume of 1.18 million, which is well above the daily average volume of 373,689. The stock has gained more than 34% in the last three trading sessions.

Find out if CTIX could maintain the momentum by getting the free full report here: http://www.wallstreetreport.net/market-scan/?symbol=CTIX